Paul Johnson
Founder presso Next Frontier Biosciences, Inc. (Colorado)
Profilo
Paul H.
Johnson is the founder of Next Frontier Biosciences, Inc. (founded in 2014) and PhaseRx, Inc. (founded in 2006).
At Next Frontier Biosciences, he holds the title of Chief Scientific Officer & Director.
At PhaseRx, Inc., he held the title of Director & Chief Scientific Officer from 2013 to 2016.
Dr. Johnson's former jobs include Director-Cell & Molecular Biology Laboratory at SRI International (1975-1994), Chief Scientific Officer at MDRNA, Inc. (2003-2007), Principal at Bayer Schering Pharma AG, Head-Cell & Molecular Biology Department at Berlex Biosciences (1994-2001), Chief Scientific Officer at EpigenX Pharmaceuticals, Inc. (2001-2003), and Professor at The Wayne State University School of Medicine.
Dr. Johnson received his undergraduate and doctorate degrees from The State University of New York.
Posizioni attive di Paul Johnson
| Società | Posizione | Inizio |
|---|---|---|
Next Frontier Biosciences, Inc. (Colorado)
 Next Frontier Biosciences, Inc. (Colorado) Pharmaceuticals: OtherHealth Technology Next Frontier Biosciences LLC develops and manufactures purified cannabinoid products for the treatment of chronic pain and other serious medical conditions. It offers nasal mist, topical salve, and sublingual spray. The company was founded by Marc Graboyes and Paul Johnson in 2014 and is headquartered in Westminster, CO. | Founder | 01/01/2014 |
Precedenti posizioni note di Paul Johnson
| Società | Posizione | Fine |
|---|---|---|
MDRNA, Inc.
 MDRNA, Inc. Miscellaneous Commercial ServicesCommercial Services MDRNA, Inc. engages in development and commercialization of innovative products based on proprietary molecular biology-based intranasal drug delivery technology. The company creates or utilizes novel formulation components or excipients that can transiently manipulate or open 'tight junctions' between cells in various tissues and thereby allow therapeutic drugs to reach the blood stream. The company is located in Hauppauge, NY. | Chief Tech/Sci/R&D Officer | 05/10/2007 |
| EpigenX Pharmaceuticals, Inc. | Chief Tech/Sci/R&D Officer | 01/01/2003 |
| Berlex Biosciences | Corporate Officer/Principal | 01/01/2001 |
SRI International
 SRI International Miscellaneous Commercial ServicesCommercial Services SRI International provides contract research and development services. It is an independent, nonprofit research institute conducting client-sponsored research and development for government agencies, commercial businesses, foundations, and other organizations. The company was founded in 1946 and is headquartered in Menlo Park, CA. | Corporate Officer/Principal | - |
| The Wayne State University School of Medicine | Corporate Officer/Principal | - |
Formazione di Paul Johnson
| The State University of New York | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| PHASERX, INC. | Health Technology |
| Aziende private | 6 |
|---|---|
MDRNA, Inc.
MDRNA, Inc. Miscellaneous Commercial ServicesCommercial Services MDRNA, Inc. engages in development and commercialization of innovative products based on proprietary molecular biology-based intranasal drug delivery technology. The company creates or utilizes novel formulation components or excipients that can transiently manipulate or open 'tight junctions' between cells in various tissues and thereby allow therapeutic drugs to reach the blood stream. The company is located in Hauppauge, NY. | Commercial Services |
| Bayer Schering Pharma AG | Health Technology |
Next Frontier Biosciences, Inc. (Colorado)
Next Frontier Biosciences, Inc. (Colorado) Pharmaceuticals: OtherHealth Technology Next Frontier Biosciences LLC develops and manufactures purified cannabinoid products for the treatment of chronic pain and other serious medical conditions. It offers nasal mist, topical salve, and sublingual spray. The company was founded by Marc Graboyes and Paul Johnson in 2014 and is headquartered in Westminster, CO. | Health Technology |
SRI International
SRI International Miscellaneous Commercial ServicesCommercial Services SRI International provides contract research and development services. It is an independent, nonprofit research institute conducting client-sponsored research and development for government agencies, commercial businesses, foundations, and other organizations. The company was founded in 1946 and is headquartered in Menlo Park, CA. | Commercial Services |
| Berlex Biosciences | |
| EpigenX Pharmaceuticals, Inc. |
- Borsa valori
- Insiders
- Paul Johnson
